Depomed Inc (DEPO): Starboard Value Blasts The Company’s Board, Hires Special Advisors

Page 29 of 32 – SEC Filing

M.	Mr. Fogarty

(a)

As of the close of business on July 26, 2016, Mr. Fogarty directly owned 16,450 Shares.

Percentage: Less than 1%

(b)

1. Sole power to vote or direct vote: 16,450

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 16,450

4. Shared power to dispose or direct the disposition: 0

(c)

Mr. Fogarty has not entered into any transactions in the Shares since the filing of Amendment No. 2 to the Schedule 13D.

N.	Mr. Lankau

(a)

As of the close of business on July 26, 2016, Mr. Lankau did not own any Shares.

Percentage: 0%

(b)

1. Sole power to vote or direct vote: 0

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 0

4. Shared power to dispose or direct the disposition: 0

(c)

Mr. Lankau has not entered into any transactions in the Shares since the filing of Amendment No. 2 to the Schedule 13D.

O.	Ms. Pendergast

(a)

As of the close of business on July 26, 2016, Ms. Pendergast did not own any Shares.

Percentage: 0%

(b)

1. Sole power to vote or direct vote: 0

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 0

4. Shared power to dispose or direct the disposition: 0

(c)

Ms. Pendergast has not entered into any transactions in the Shares since the filing of Amendment No. 2 to the Schedule 13D.

P.	Mr. Savage

(a)

As of the close of business on July 26, 2016, Mr. Savage did not own any Shares.

Percentage: 0%

(b)

1. Sole power to vote or direct vote: 0

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 0

4. Shared power to dispose or direct the disposition: 0

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

---

or

Subscribe with Google

We may use your email to send marketing emails about our services. Click here to read our privacy policy.